Boston Mountain Biotech, LLC

FAYETTEVILLE, AR · Founded 2017 · CIK 0001707462 · Biotech · Defunct

Unable to determine

boston.com →
Grants
$270K
1 award
Sector median: 1
Raised
$8.4M
1 Form D · May 2017
112 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Harnessing CRISPR-mediated silencing for the one-step optimization of protein production strains$269,757
Private capital raisedForm D · SEC$8,400,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1931Prologue Medicines——
1932Akeso Therapeutics Inc——
1933XEME Biopharma, Inc.—$10M
1934Boston Mountain Biotech, LLC—$8.4M
1935ANGIOTENSIN THERAPEUTICS, INC.——
1936CELLARCUS TECHNOLOGIES, LLC——
1937DeepSpace Storage Systems Inc.—$1.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Ellen BruneExecutive Officer
  • Ricky DraehnExecutive Officer
  • Tracie DraehnDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.